| Literature DB >> 27363879 |
Nicole M Fett1, David Fiorentino2, Victoria P Werth3.
Abstract
Patients with skin-predominant lupus erythematosus, dermatomyositis, and morphea should be evaluated, treated, and followed by dermatologists who can take primary responsibility for their care. Many academic centers have specialized centers with dermatologists who care for these patients. Patients with skin-predominant lupus erythematosus should be followed regularly with laboratory tests to detect significant systemic disease. Antibody tests can help determine the risks for individual patients. Patients with morphea rarely progress to systemic disease, but therapies can be helpful in treating and preventing progression of disease. Published by Elsevier Inc.Entities:
Keywords: Dermatomyositis; Educational gaps; Lupus; Morphea; Practice
Mesh:
Year: 2016 PMID: 27363879 PMCID: PMC5514844 DOI: 10.1016/j.det.2016.02.006
Source DB: PubMed Journal: Dermatol Clin ISSN: 0733-8635 Impact factor: 3.478